MS-SMART Trial: a multi-arm phase 2b randomised, double blind, parallel group, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis [NCT01910259]

MS -SMART Investigators

MS-SMART Trial: a multi-arm phase 2b randomised, double blind, parallel group, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis [NCT01910259]

MS -SMART Investigators

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	986-987
Number of pages	2
Journal	Multiple Sclerosis Journal
Volume	24
Publication status	Published - 12 Oct 2018
Event	34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) - Berlin, Germany Duration: 10 Oct 2018 → 12 Oct 2018

Cite this

@article{16d1e6dbe0ef41e1bfe6368c5efbc7a7,

title = "MS-SMART Trial: a multi-arm phase 2b randomised, double blind, parallel group, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis [NCT01910259]",

author = "{MS -SMART Investigators} and J. Chataway and {De Angelis}, F. and P. Connick and R. Parker and D. Plantone and A. Doshi and N. John and J. Stutters and D. Macmanus and F. Prados and F. Barkhof and M. Braisher and M. Ross and G. Cranswick and S. Pavitt and G. Giovannoni and Wheeler-Kingshott, {C. A. M. Gandini} and C. Hawkins and B. Sharrack and R. Bastow and Weir, {C. J.} and N. Stallard and S. Chandran",

year = "2018",

month = oct,

day = "12",

language = "English",

volume = "24",

pages = "986--987",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications",

note = "34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) ; Conference date: 10-10-2018 Through 12-10-2018",

}

MS-SMART Trial: a multi-arm phase 2b randomised, double blind, parallel group, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis [NCT01910259]. / MS -SMART Investigators.
In: Multiple Sclerosis Journal, Vol. 24, 12.10.2018, p. 986-987.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - MS-SMART Trial

T2 - 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)

AU - MS -SMART Investigators

AU - Chataway, J.

AU - De Angelis, F.

AU - Connick, P.

AU - Parker, R.

AU - Plantone, D.

AU - Doshi, A.

AU - John, N.

AU - Stutters, J.

AU - Macmanus, D.

AU - Prados, F.

AU - Barkhof, F.

AU - Braisher, M.

AU - Ross, M.

AU - Cranswick, G.

AU - Pavitt, S.

AU - Giovannoni, G.

AU - Wheeler-Kingshott, C. A. M. Gandini

AU - Hawkins, C.

AU - Sharrack, B.

AU - Bastow, R.

AU - Weir, C. J.

AU - Stallard, N.

AU - Chandran, S.

PY - 2018/10/12

Y1 - 2018/10/12

M3 - Meeting abstract

SN - 1352-4585

VL - 24

SP - 986

EP - 987

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

Y2 - 10 October 2018 through 12 October 2018

ER -